
FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment
The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

The first doses of the newly approved Alzheimer’s drug “Leqembi” were administered in Louisville. More than 100 people have signed up since then. See why.

Biogen reprioritize resources allocated to ADUHELM® to advance LEQEMBI®.

At long last, we finally have a disease-modifying drug for Alzheimer’s. The FDA recently approved a new drug that promises to slow the progression of the disease. Only five Alzheimer’s treatments have been approved by the FDA up until a decade ago, and this is only the second to address the progression of the disease.

FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.

A neuroradiologist at the Mayo Clinic in Jacksonville, FL warns that increased use of monoclonal antibody treatment for Alzheimer’s has also led to the discovery of amyloid-related imaging abnormalities — ARIA. Find out more.

The first drugs for Alzheimer’s disease emerged in the 1990s, but since then there has been a wave of clinical trial failures, major companies pulling resources from neuroscience R&D, and progress.

Most of the time, it takes a combination of genetics, bad environment and unhealthy lifestyle to trigger Alzheimer’s. However, one gene called apolipoprotein E (APOE) can make a big difference.

A new study suggests that very low sodium intake may be linked to faster memory decline in older adults.

Mayo Clinic, America’s top research center, asked, “Is Alzheimer’s triggered by a form of brain diabetes?” An insulin nasal spray may help.

Researchers say it takes a dozen “intervention sessions” to improve cognition in those at risk for Alzheimer’s and other dementias.

FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.

This carpool sing-a-long between a father with dementia and his son went viral. $50,000 in donations poured into the Alzheimer’s Society. Enjoy their great music. Sing along if you can!

Verna and Jerry Kinersly were happily married for nearly 68 years. See why they were glad to have found the Lou Ruvo Center for Brain Health.
No spam, only news and updates.


